Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLY
2801
DELISTED
Fly Leasing Limited
FLY
| $1.07M | ﹤0.01% |
+77,102
| New | +$911K |
|
2802
Santander
BSBR
$43.4B
| $1.06M | ﹤0.01% |
98,756
+61,101
| +162% | +$730K |
|
2803
Assured Guaranty
AGO
$3.3B
| $1.06M | ﹤0.01% |
23,874
-122,741
| -84% | -$5.11M |
|
2804
PUT
Nike
NKE
$58.6B
| $1.06M | ﹤0.01% |
+12,600
| New | +$1.04M |
|
2805
CALL
Aurinia Pharmaceuticals
AUPH
$2.23B
| $1.06M | ﹤0.01% |
+163,000
| New | +$1.08M |
|
2806
Matinas BioPharma
MTNB
$2.9M
| $1.06M | ﹤0.01% |
+19,378
| New | +$1.04M |
|
|
CRC
2807
DELISTED
California Resources Corporation
CRC
| $1.05M | ﹤0.01% |
41,009
-52,369
| -56% | -$1.13M |
|
2808
Bankwell Financial Group
BWFG
$524M
| $1.04M | ﹤0.01% |
35,804
+2,933
| +9% | +$85.9K |
|
|
CCF
2809
DELISTED
Chase Corporation
CCF
| $1.04M | ﹤0.01% |
+11,292
| New | +$1.08M |
|
2810
OraSure Technologies
OSUR
$261M
| $1.04M | ﹤0.01% |
93,642
-213,792
| -70% | -$2.48M |
|
2811
Lear
LEA
$8.23B
| $1.04M | ﹤0.01% |
7,675
-274,851
| -97% | -$40.3M |
|
2812
Ituran Location and Control
ITRN
$1.01B
| $1.03M | ﹤0.01% |
+30,313
| New | +$1.04M |
|
2813
Lands' End
LE
$368M
| $1.03M | ﹤0.01% |
+62,223
| New | +$1.06M |
|
|
BRQS
2814
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
| $1.03M | ﹤0.01% |
1,127
-6
| -0.5% | -$4.92K |
|
2815
CVB Financial
CVBF
$3.94B
| $1.03M | ﹤0.01% |
+49,090
| New | +$1.08M |
|
2816
Collegium Pharmaceutical
COLL
$852M
| $1.03M | ﹤0.01% |
68,038
-1,236,963
| -95% | -$19.8M |
|
2817
Genuine Parts
GPC
$19B
| $1.03M | ﹤0.01% |
9,190
-850,211
| -99% | -$88M |
|
|
KNDI
2818
Kandi Technologies Group
KNDI
$66.3M
| $1.03M | ﹤0.01% |
+183,424
| New | +$1.14M |
|
2819
Tecnoglass Holdings
TGLS
$1.79B
| $1.03M | ﹤0.01% |
+141,323
| New | +$1.16M |
|
2820
Vanguard Total World Stock ETF
VT
$81.2B
| $1.03M | ﹤0.01% |
+14,065
| New | +$998K |
|
2821
ATI
ATI
$29.3B
| $1.03M | ﹤0.01% |
40,177
-546,483
| -93% | -$14.4M |
|
2822
PUT
Cencora
COR
$62.6B
| $1.03M | ﹤0.01% |
+12,900
| New | +$1.04M |
|
|
XONE
2823
DELISTED
The ExOne Company
XONE
| $1.03M | ﹤0.01% |
120,811
+21,780
| +22% | +$201K |
|
2824
NRC Health Common Stock
NRC
$487M
| $1.02M | ﹤0.01% |
+26,544
| New | +$1.04M |
|
2825
PUT
AutoZone
AZO
$49.4B
| $1.02M | ﹤0.01% |
1,000
-1,000
| -50% | -$898K |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.